Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscula Supply Disruption — Amneal Pharmaceuticals of New
Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscula Supply Disruption — Amneal Pharmaceuticals of New is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscula; Manufacturer: Amnea
| Drug name | Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscula |
|---|---|
| Manufacturer | Amneal Pharmaceuticals of New York, LLC |
| Recall/Disruption reason | Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Fo |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0756-2023 |
| Initiation date | 20230508 |
| Quantity affected | 69,239 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →